Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 31 % of short-term debt in 2025; threshold 65 %.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
SV Perfusion from Profondeville, company number BE0736634331, closed financial year 2025 with a result of € 61,196 after tax. For that financial year SV Perfusion recorded revenue of € 156,782 and equity of € 234,491. Compared with financial year 2024, the result moved from € 58,809 to € 61,196. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 10, 2026.
€ 234,491
▲ 10% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 61,196
▲ 4% vs 2024
Profit after tax over the fiscal year.
€ 3,393
▼ 98% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 40,000 paid out
65 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 3,817
▼ 53% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 726
▼ 16% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 11,958
▲ 61% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 121,564 | € 149,519 | € 158,043 | € 156,782 | ▼ 1% |
| Gross margin | € 44,649 | € 73,223 | € 84,446 | € 90,437 | ▲ 7% |
| Profit after taxes | € 29,677 | € 50,291 | € 58,809 | € 61,196 | ▲ 4% |
| Equity | € 104,195 | € 154,486 | € 213,295 | € 234,491 | ▲ 10% |
| Total debts | € 19,771 | € 14,891 | € 14,620 | € 55,898 | ▲ 282% |
| Cash | € 108,669 | € 154,116 | € 204,610 | € 3,393 | ▼ 98% |
| Retained profit | € 101,195 | € 151,486 | € 210,295 | € 231,491 | ▲ 10% |
| Dividend | € 0 | € 0 | € 0 | € 40,000 | |
| Balance sheet total | € 123,966 | € 169,377 | € 227,915 | € 290,389 | ▲ 27% |
Key figures of SV Perfusion, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to SV Perfusion?
What happened at SV Perfusion in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 61,196 (▲ 4% vs 2024). filed late Source: NBB ↗
- New establishment in Profondeville. KBO
- Start of the company according to the CBE. KBO
In short
From € 29,677 profit in 2022 to € 61,196 profit in 2025.
Paid € 80,250 in corporate taxes since 2022.
Best year ever: 2025, with € 61,196 profit.
Paid out € 40,000 in dividends to the owners in total.
Establishments
Establishment units
Physical locations of this company
Avenue du Grand Verger 15
5170 Profondeville
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0736.634.331
- VAT number
- BE 0736.634.331
- Registered office
- Avenue du Grand Verger 15, 5170 Profondeville
- Names & denominations
- SV Perfusion
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 October 2019
- Peppol
- Not registered
- Contact
- [email protected] +32497401453